A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

The Society of Gynecologic Oncology (SGO) will convene leading experts in gynecologic oncology at its 2026 Annual Meeting on Women's Cancer, to be held April 10–13, 2026, in San Juan, Puerto Rico. The ...

AI and clinical trial access may hold the key to reducing oncology denials, as experts from PayerWatch and Massive Bio ...

SynOx Therapeutics completed enrollment for the phase 3 TANGENT study of emactuzumab for tenosynovial giant cell tumors, with results expected in 2026. ALX Oncology launched a phase 1 trial of ALX2004 ...

Oncology clinical trials are complex and costly, making a successful setup critical. Facing challenges such as long timelines and patient recruitment, patient-centric approaches such as AI, digital ...

Martei is a medical oncologist, cancer outcomes researcher, and an assistant professor of medicine at the University of Pennsylvania. At the American Society of Clinical Oncology annual meeting last ...

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to ...

Partnership will enhance physician awareness of START's portfolio of trials, streamline referrals, and support patient access to early-phase oncology research SAN ANTONIO and BARCELONA, Spain, March ...

The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...